GEN - Genetic Engineering and Biotechnology News
Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
Top 25 Biotech Companies of 2024 - genengnews.com
Jan 12, 2024 · Just missing the list at number 26 is BioMarin Pharmaceutical, which had a market cap of $17.51 billion on December 8, followed by WuXi Biologics ($15.94 billion), UCB ($15.52 billion), Novozymes ...
Illumina Launches New MiSeq i100 Series with XLEAP Chemistry, …
Oct 9, 2024 · The MiSeq i100 System costs just over $49,000 and the MiSeq i100 Plus system costs just over $109,000. The speed depends on the flow cell being used, with run times less than four hours for ...
Top 10 RNA-Based Biopharmas - genengnews.com
Nov 17, 2021 · In GEN’s initial A-List published in 2018, the top five public companies generated a combined $1.536 billion in revenues for 2017 and the first three quarters of 2018.By contrast, the top five ...
Bruker Unveils Spatial Strategy Post NanoString Acquisition
Oct 11, 2024 · Three months later, NanoString was acquired by Bruker for approximately $392.6 million in cash and the assumption of certain liabilities. But Bruker remained tight-lipped about its intentions ...
Baker, Hassabis, Jumper Awarded Nobel Prize in Chemistry for …
Oct 9, 2024 · Baker will be a keynote speaker at GEN’s inaugural summit on the State of AI in Drug Discovery which will be held on October 30. David Baker won the 2024 prize for computational protein design ...
Top 10 Biomedical Issues of the Next Decade - genengnews.com
Feb 1, 2020 · Gene therapies are still in use, but genetic medicine and counseling are shifting toward prevention. Some governments are taking an interest in encouraging gene editing to control the high cost of ...
Making History with the 1990 Gene Therapy Trial
Mar 10, 2016 · At the age of four years, DeSilva made history at 12:52 p.m. on September 14, 1990, as the first patient to undergo an approved application of gene therapy. She was part of a trial authorized by ...
Top 10 Biopharma Takeover Targets of 2024 - genengnews.com
Feb 1, 2024 · The total value of biotech M&A in 2023 stood at $122.2 billion, up 45% from $84.2 billion a year earlier. The total value of pharma M&A jumped 38% year over year, from $98.5 billion in 2022 to ...
MilliporeSigma Opens Glitzy $286 Million Biosafety Testing Facility …
Oct 10, 2024 · The new 23,000-square-meter facility, built on a vacant plot of land, will house MilliporeSigma’s biosafety testing, analytical development, and cell banking manufacturing services. The cost of ...